GPhA Questions FDA’s Use of ICH Guidance In Draft Stability Testing Requirements

Generic Line
The Generic Pharmaceutical Association (GPhA) is questioning the FDA’s use of an International Conference on Harmonisation (ICH) guideline to specify ANDA testing requirements when it was originally intended for new drug substances and products.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00